Study on the Recovery of Pulmonary Function Chest CT Hematologic and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients

  • participants needed
  • sponsor
    Wuhan Union Hospital, China
Updated on 10 August 2022
chest ct
coronavirus infection


The intent of this study was to examine the recovery of individuals who had been hospitalized for COVID-19 in the year following their discharge from the hospital. Parameters studied included serum levels of SARS coronavirus 2 (SARS-CoV 2) IgG antibody, tests of lung function, and imaging data to evaluate changes in lung fibrosis. In addition, we explored the systematic Immune & Inflammation in some of the individuals recovering from COVID-19.


About 20% of COVID-19 developed into a critical illness and about 2% died. The global epidemic continues to develop, but some patients in China have entered the rehabilitation period, which is accompanied by a large number of respiratory symptoms and pulmonary fibrosis, bringing serious harm to the country. Therefore, early accurate detection and prediction of the development trend of patients in rehabilitation period and targeted treatment measures for corresponding patients are the key to the success of COVID-19 rehabilitation period. It will play a key role in the stratified management of the post-epidemic situation, which is crucial to improve the quality of life of COVID-19 patients. We aim to explore the clinical characteristics of rehabilitation patients by detecting some indicators of patients in rehabilitation period, including serum IgG and IgM antibody of SARS-CoV 2, pulmonary function, chest CT imaging, systematic Immune & Inflammation states.

Condition *COVID-19, Covid-19
Clinical Study IdentifierNCT04456101
SponsorWuhan Union Hospital, China
Last Modified on10 August 2022

Similar trials to consider


Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 



Reply by • Private

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note